Antipsychotic dose increase or stay in non-responders with schizophrenia: A double-blind randomized controlled trial
Not Applicable
- Conditions
- schizophrenia, schizoaffective disorder, persistent delusional disorder
- Registration Number
- JPRN-UMIN000008667
- Lead Sponsor
- Inokashira Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Concomitant use of another antipsychotic drug within the last 4 weeks (2) Past history of non-response or intolerability to the maximum dose of the current antipsychotic drug (i.e., olanzapine 20 mg/d; risperidone 6 mg/d) (3) Active suicidal ideations or past suicide attempts (4) Severe physical disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method